Navigation Links


Sarcoma at Biology News

Novel gene-silencing nanoparticles shown to inhibit Ewing's sarcoma

A novel delivery system that transports gene silencing nanoparticles into tumor cells has been shown to inhibit Ewing's sarcoma in an animal model of the disease. In this classic "Trojan horse" approach, a protein called transferrin that normally delivers iron into cells is modified to also smuggle into tumor cells siRNA (short interfering RNA) encased in nano-sized sugar polymers. The si...

Landmark discovery of a Kaposi's sarcoma-associated herpesvirus receptor

Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and certain forms of lymphoma. Kaposi's sarcoma is a major cancer associated with HIV/AIDS, and it typical...

Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors

A study in the January 3 issue of the quantifies the risk of hereditary retinoblastoma survivors developing specific subtypes of soft tissue sarcomas and finds that this risk persists for decades after the original retinoblastoma diagnosis. The findings emphasize the importance of regular medical surveillance for these patients, the authors say. </p...
Sarcoma at Biology Products

A - 20 cell line slides ( mouse: B lymphocyte; reticulum cell sarcoma ) from GeneTex

Description:Mouse A-20 cells were cultured in RPMI 1640 with 2 mM L-glutamine and harvested at the log phase of growth. In order to keep the antigens in their native forms, cells were fixed in acetone-methanol. The cells are arrayed on a 12-well (5 mm) adhesive coated slide, with each wells surface specifically treated to enhance cellular attachment and to minimize background staining. Each well is loaded...
Company:GeneTex
Sarcoma at Biology Technology
Sarcoma at Medicine News

Kissing can cause Kaposi’s Sarcoma in AID

Kisssing may be responsible for a form of the herpes virus that causes an AIDS-related skin cancer called Kaposi’s sarcoma. Kaposi’s sarcoma causes purple skin blotches and can also attack the internal organs. The virus rarely causes sickness among people with normal disease defenses but attacks those with weakened immune system as in AIDS. The virus known as herpes virus 8...

Effect of Osteosarcoma predicted by scans

Researchers have been studying about the outcome of the hitech scanning technologies recently. A scan that looks at glucose uptake in a tumour shows who has a poor prognosis. Osteosarcoma is a bone tumour which affects mainly younger people. //It's an unusual cancer and one where the outcome tends to be rather unpredictable. Researchers at the University of Germany have used a technique called...

Virus Causing Kaposi's Sarcoma Discovered

Virus causing Kaposi's sarcoma herpesvirus (KSHV) and certain forms of lymphoma has been discovered, according to a recent report from NIAID.// Researchers at the National Institute of Allergy and Infectious Disease (NIAID) have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and cert...

Risk Of Soft Tissue Sarcomas In Hereditary Retinoblastoma Survivors

A study by Ruth A. Kleinerman and his colleagues quantifies the risk of hereditary retinoblastoma survivors developing specific subtypes of soft tissue sarcomas and finds that// this risk persists for decades after the original retinoblastoma diagnosis. The findings published in the January 3 issue of the Journal of the National Cancer Institute emphasizes the importance of regular med...

Insights into Osteosarcoma in Cats and Dogs may Improve Palliative Care

Researchers at the University of Illinois have found that a molecular pathway known to have a role in the progression of bone cancer in humans is also critical to the pathology// of skeletal tumors in dogs and cats. Their work could lead to advances in the palliative care of companion animals afflicted with osteosarcoma. The research team, which included U. of I. pathobiology professo...

More>>

Sarcoma at Medicine Products

Ewing Sarcoma by RT-PCR

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Kaposi Sarcoma-Associated Herpesvirus/Human Herpesvirus 8

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Rhabdomyosarcomas

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Sarcoma at Medicine Technology

Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology

LUGANO, Switzerland--(BUSINESS WIRE)--Jul 9, 2007 - ZIOPHARMOncology, Inc. (NASDAQ: ZIOP) announces that positive interim datafrom an ongoing phase II trial of ZIO-201 (isophosphoramide mustard- IPM) to treat advanced sarcoma patients was presented at theEuropean Society of Medical Oncology (ESMO) meeting held July 5-8,2007 in Lugano, Switzerland. The abstract entitled, "Phase-I/IIStudy of...

GSK'S Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline todayannounced results from ongoing Phase II studies of pazopanib inadvanced or metastatic renal cell carcinoma (RCC), ovarian cancerand soft tissue sarcoma (STS). These trials were presented at the43rd Annual Meeting of the American Society of Clinical Oncology(ASCO) in Chicago. The results observed in these trials withpazopanib sup...

Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared to Chemotherapy Alone for Sarcoma Cancer Patients

SALT LAKE CITY, June 04, 2007 /PRNewswire-FirstCall/ -- BSDMedical Corp. announced today that the results of a 340 patientrandomized Phase III clinical trial testing the benefit of addinghyperthermia therapy to chemotherapy were presented at the annualAmerican Society of Clinical Oncology (ASCO) conference underway inChicago, Illinois. According to the results of this clinical study,whic...
Sarcoma at Medicine Dictionary

Sarcoma

AID...

Rhabdomyosarcoma

, there is usually an a...

Osteosarcoma

What is most often occurs in <a href="/ ?q=...

Leiomyosarcoma

virtually anywhere in the body, although it tends to develop in <a hr...
Other TagsChicagoChicagoCompanyCompanyCompanyCompanyLucigenLucigenBiomedicalBiomedicalMirusMirusBrandingFiservAuroraPatentPatent
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/24/2008)... , July 24, 2008 A new study by researchers from...alth addresses one of the most challenging issues ...V transmission in poor countries. In these settin... the best outcome for their infants, they should e...g four to six months after birth. But according to...
(Date:7/24/2008)... , Irvine, Calif. UC Irvine researchers have f...ur own body clock and metabolism. The discovery r...etes, obesity and other related diseases. , Paol... of Pharmacology, and his colleagues have identifi...ulates the body,s circadian rhythms, works in bala...
(Date:7/24/2008)... , PORTLAND, Ore. July 23, 2008. A fire is curren... were made about fire behavior about 2 years ago. ...ate-Successional Reserve (LSR) study in the planni...r where the Cold Springs fire is now active., Th...de Range in Washington, and covers about 15,000 ac...
(Date:7/23/2008)... , COLUMBUS, Ohio Wealthy nations willing to col...event the emission of roughly half a billion metri...years, new research suggests. , It would take a...he tropical deforestation in the world, one of the...earchers estimate. , If adopted, this type of pr...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 1Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 1Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 1iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 2iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 4Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 1Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 4
Other Contentsrepulsionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresponseresponseresponseresponseresponseresponseresponseresponseresponseresponseresponsivenessresponsivenessresponsivenessresponsivenessresponsivenessrestingrestingrestingrestingrestingrestingrestingrestingenzymesenzymesenzymesenzymesenzymesenzymesenzymesenzymeslysatelysatereticulocytereticulocyte